Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-17-000218
Filing Date
2017-07-14
Accepted
2017-07-14 14:35:17
Documents
43
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 mainbody.htm 10-K 353096
2 GRAPHIC image_001.jpg GRAPHIC 8371
3 GRAPHIC image_002.jpg GRAPHIC 13070
4 ex10_1.htm EX-10.1 53210
5 ex31_1.htm EX-31.1 9083
6 ex31_2.htm EX-31.2 9083
7 ex32_1.htm EX-32.1 4023
  Complete submission text file 0001663577-17-000218.txt   1386636

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE vibi-20170331.xml EX-101.INS 118035
9 XBRL SCHEMA FILE vibi-20170331.xsd EX-101.SCH 20612
10 XBRL CALCULATION FILE vibi-20170331_cal.xml EX-101.CAL 12824
11 XBRL DEFINITION FILE vibi-20170331_def.xml EX-101.DEF 31544
12 XBRL LABEL FILE vibi-20170331_lab.xml EX-101.LAB 109242
13 XBRL PRESENTATION FILE vibi-20170331_pre.xml EX-101.PRE 91068
Mailing Address THE SEAGRAM BUILDING, 375 PARK AVENUE SUITE 2607 NEW YORK CITY NY 10152
Business Address THE SEAGRAM BUILDING, 375 PARK AVENUE SUITE 2607 NEW YORK CITY NY 10152 (646) 875-5747
Vilacto Bio Inc. (Filer) CIK: 0001576724 (see all company filings)

EIN.: 463883208 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55023 | Film No.: 17965350
SIC: 7372 Services-Prepackaged Software